| Informed consent and the elusive dichotomy between standard and experimental therapy L Noah American Journal of Law & Medicine 28 (4), 361-408, 2002 | 174 | 2002 |
| Administrative arm-twisting in the shadow of congressional delegations of authority L Noah Wis. L. Rev., 873, 1997 | 174 | 1997 |
| The imperative to warn: Disentangling the right to know from the need to know about consumer product hazards L Noah Yale J. on Reg. 11, 293, 1994 | 171 | 1994 |
| Assisted reproductive technologies and the pitfalls of unregulated biomedical innovation L Noah Fla. L. Rev. 55, 603, 2003 | 145 | 2003 |
| Medicine's epistemology: Mapping the haphazard diffusion of knowledge in the biomedical community L Noah Ariz. L. Rev. 44, 373, 2002 | 142 | 2002 |
| Advertising prescription drugs to consumers: assessing the regulatory and liability issues L Noah Ga. L. Rev. 32, 141, 1997 | 140 | 1997 |
| Pigeonholing illness: medical diagnosis as a legal construct L Noah Hastings LJ 50, 241, 1998 | 114 | 1998 |
| Divining Regulatory Intent: The Place for a Legislative History of Agency Rules L Noah Hastings LJ 51, 255, 1999 | 113 | 1999 |
| Civil jury nullification L Noah Iowa L. Rev. 86, 1601, 2000 | 111 | 2000 |
| Rewarding Regulatory Compliance: The Pursuit of Symmetry in Products Liabiility L Noah Geo. LJ 88, 2147, 1999 | 106 | 1999 |
| Interpreting agency enabling acts: Misplaced metaphors in administrative law L Noah Wm. & Mary L. Rev. 41, 1463, 1999 | 104 | 1999 |
| Ambivalent commitments to Federalism in Controlling the Practice of Medicine L Noah U. Kan. L. Rev. 53, 149, 2004 | 102 | 2004 |
| Starting from Scratch: Reinventing the Food Additive Approval Process L Noah, RA Merrill BUL Rev. 78, 329, 1998 | 102 | 1998 |
| Scientific republicanism: Expert peer review and the quest for regulatory deliberation L Noah Emory LJ 49, 1033, 2000 | 94 | 2000 |
| The Little Agency That Could (Act with Indifference to Constitutional and Statutory Strictures) L Noah Cornell L. Rev. 93, 901, 2007 | 82 | 2007 |
| A Miscarriage in the Drug Approval Process: Mifepristone Embroils the FDA in Abortion Politics L Noah Wake Forest L. Rev. 36, 571, 2001 | 81 | 2001 |
| Reconceptualizing Federal Preemption of Tort Claims as the Government Standards Defense L Noah Wm. & Mary L. Rev. 37, 903, 1995 | 78 | 1995 |
| The Coming Pharmacognomics Revolution: Tailoring Drugs to Fit Patients' Genetic Profiles L Noah Jurimetrics 43, 1, 2002 | 70 | 2002 |
| Governance by the Backdoor: Administrative Law (lessness) at the FDA L Noah Neb. L. Rev. 93, 89, 2014 | 69 | 2014 |
| This Is Your Products Liability Restatement on Drugs L Noah Brooklyn Law Review 74, 2009 | 69 | 2009 |
